PAR DRUGS AND CHEMICALS
|
The Current P/B Ratio of PAR DRUGS AND CHEMICALS is 0.95.
| Share Price | ₹86.7 | Jun 04,2026 |
| Market Cap | ₹106.7 Cr | |
| Book Value | ₹112.0 Cr | Mar2026 - Standalone Results |
| Price/Book | 0.95x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of PAR DRUGS AND CHEMICALS
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹106.7 Cr] as on Jun 04,2026
(/) Book Value [ ₹112.0 Cr] based on Mar2026 - Standalone Results
(=) P/B Ratio [ 0.95x ]
Thus, for PAR DRUGS AND CHEMICALS , the investors are currently willing to pay '0.95 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of PAR DRUGS AND CHEMICALS !
The chart below summarizes the trend in P/B Ratio of PAR DRUGS AND CHEMICALS over the last five years.
Historical PB (Price/Book ) ratio chart of PAR DRUGS AND CHEMICALS
PB Ratio Performance Analysis for PAR DRUGS AND CHEMICALS
- PAR DRUGS AND CHEMICALS 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.26x.
- PAR DRUGS AND CHEMICALS 's operated at median p/b ratio of 2.42x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PAR DRUGS AND CHEMICALS 's p/b ratio peaked in Mar2022 at 3.28x.
- PAR DRUGS AND CHEMICALS 's p/b ratio hit its five-year low in Mar2025 of 1.06x.
How does PAR DRUGS AND CHEMICALS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| PAR DRUGS AND CHEMICALS | 111.99 | 0.95 | 106.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.11 | 426,926.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 10.44 | 175,062.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 17.50 | 146,806.0 |
| CIPLA LTD | 34,369.40 | 3.29 | 112,910.0 |
| DR REDDYS LABORATORIES LTD | 37,891.50 | 2.79 | 105,755.0 |
| MANKIND PHARMA LTD | 16,300.30 | 5.96 | 97,215.3 |
| LUPIN LTD | 22,448.30 | 4.58 | 102,814.0 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.03 | 109,222.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.22 | 84,212.3 |
| LAURUS LABS LTD | 5,300.06 | 14.54 | 77,048.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs PAR DRUGS AND CHEMICALS 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 0.95x |
| Max industry PB | 17.50x |
| Median industry PB | 4.58x |
| Average industry PB | 6.49x |
You may also like the below Video Courses